Cost effectiveness of sunitinib.
Trippoli
Sabrina
S
Messori
Andrea
A
D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D003362:Cost-Benefit Analysis; D003627:Data Interpretation, Statistical; D016527:Drug Costs; D006801:Humans; D007211:Indoles / Q000191:economics / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics / Q000401:mortality; D011758:Pyrroles / Q000191:economics / Q000627:therapeutic use; D000077210:Sunitinib; D016019:Survival Analysis; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib